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This prospective study of the elderly population estimated the risks of smoking for morbidity and mortality
and identified whether cessation of smoking reduced the risk of disease. Data came from face-to-face
interviews that used a population-based probability sample of those aged 60 years or over in Taiwan,
provided by the Population and Health Research Center, Bureau of Health Promotion. In total, 4,049 subjects
were included at the baseline year of 1989 and followed up in 1993 and 1996. Smoking-related variables
included current smoking status, smoking history, daily consumption, and years since the cessation of
smoking. Cox regression models were used to analyze the relative risks for morbidity and mortality,
controlling for demographics, physical function, and comorbidities. The sample was made up of 50.2%
nonsmokers, 15.2% ex-smokers, and 34.6% current smokers in the baseline year. Current smokers were
more likely to have lower respiratory tract diseases throughout the study. Current smokers had a higher
risk of stroke from 1989 to 1993. No dose-response relationship for smoking exposure or impact of years
since smoking cessation was found. Whether cessation of smoking is protective should be investigated
for middle-aged adults followed to old age. An effective strategy for smoking cessation in the elderly
is suggested, and people should be encouraged to quit smoking at any time.
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Smoking is an important health hazard in mortality. It is
estimated that about 3 million people die each year from
smoking-related diseases, and this will increase to over 10
million worldwide by 2025 [1]. Many prospective studies
have identified cigarette smoking as an important risk
factor for cardiovascular disease, chronic bronchitis, several
types of cancer, and other diseases [2–13].
There is evidence that a reduction in risk occurs on
quitting smoking. The reduction in risk for heart disease is
linked to the duration of cessation [14]. Smoking cessation
can reduce the risk of mortality, and smoking cessation af-
ter acute myocardial infarction can reduce the relative risk
(RR) of death by between 15% and 61% [15]. Smoking
cessation may increase lung function and lower mortality
for male smokers [16]; even an interrupted cessation of
smoking is helpful and can improve lung function.
Only a few studies of the impact of smoking on health in
Taiwan have been reported. A prospective cohort study
explored the attributable risk of cigarette smoking to death
from various diseases in township residents aged 40 or over
[17]. The RR of mortality for male smokers was 1.3, and 1.5
in all cancers. The RRs for stomach disease, ischemic and
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other heart diseases, and chronic obstructive pulmonary
disease (COPD) ranged from 1.4 to 1.9, with higher RRs for
females. The attributable risks for mortality associated with
smoking were 21.3% and 2.9% for males and females, re-
spectively. In another case-control study, the risk of lung
cancer was significantly higher in smokers than in non-
smokers [18]. Even for those who had stopped smoking, the
RRs were higher at 6.39 and 4.00. The risk for every pack of
cigarettes smoked was 1.04. The risk of a smoking history
over 25 years for nasopharyngeal cancer in Taiwan was 1.7
compared to nonsmokers [19]. In Taiwan, smoking cessation
projects and intervention programs have been developed
[20–23]. However, evidence that cessation of smoking re-
duces the risk of disease and mortality is limited [24].
The question of whether smoking cessation reduces
health hazard risks for the elderly is important for the
attractive strategy of health promotion as a way of achieving
successful aging [25]. However, few studies have shown
that smoking cessation has an impact on morbidity and
mortality in old age. Also, there have been no prospective
follow-up studies targeting the elderly population to esti-
mate the risks of smoking and the effect of smoking cessation
on morbidity and mortality. Therefore, to explore the effects
of smoking cessation on the risk of disease will be useful as
a basis for the development of a health promotion strategy
for the elderly and to attain the goal of successful aging.
The purpose of this study was to use prospective elderly
samples with 7-year follow-up to assess the impact of
smoking status on morbidity and mortality, and examine
whether cessation of smoking reduced the risks of diseases
in old age.
METHODS
Data and samples
Data came from a face-to-face interview, the “Study of
Health and Living Status of the Elderly” a national repre-
sentative elderly sample from a survey conducted by the
Population and Health Research Center, Bureau of Health
Promotion. Samples were of people aged 60 years or over
and drawn randomly from the entire elderly population in
Taiwan with 1989 as the baseline, and then followed up in
1993 and 1996. Sampling was made up of a three-stage
probability sample. All interviews were conducted by senior
interviewers under high quality control. In this study, we
used the 1989 sample as the baseline (n = 4,049), together
with follow-up data for 1993 (n = 3,155) and 1996 (n = 2,669,
aged 67 years or over). Completion rate (excluding deaths)
for 1989, 1993 and 1996 were 91.8%, 91.0%, and 88.9%. There
were no differences in age, sex, and smoking status among
the completed cases and those missing through loss or
death from the initial sample when examined for goodness-
of-fit.
Variables
Dependent variables were self-reported chronic diseases
and mortality. Diseases included heart disease, stroke, lower
respiratory tract diseases (asthma, bronchitis, tuberculosis),
diabetes, digestive system diseases (ulcer, gastrointestinal
problems, liver/gallbladder diseases), kidney diseases, and
cancer (only surveyed in 1993 and 1996).
The major independent variables related to smoking
were current smoking status (nonsmokers, who had never
smoked; ex-smokers, who quit smoking; and current
smokers), smoking history (starting age of smoking, years
of quitting), and smoking exposure (cumulative smoking
years, amount smoked every day). The cumulative smoking
years were defined from the age of starting smoking to the
survey year. If the subject had quit smoking, their smoking
history was also counted. The cumulative smoking years
for those who never smoked was defined as zero.
Controlled risk factors included age (60–74, ≥ 75 years),
gender, education (low = illiterate, no formal education,
elementary school; medium = junior high school; high =
senior high school or over), ethnic group (Ming-Nan, others
including Hakka, mainland provinces, etc), disability in
physical function in 1989 (any difficulties caused by health
problems in shopping for personal items, management of
money, making phone calls, and taking a bath alone).
Analysis
The incidence of each disease was estimated. The RRs and
population-attributable risk (PAR) of smoking status on
morbidity and mortality were estimated using Cox
proportional hazards regression models. Three kinds of
smoking effects were analyzed. First, the risk of smoking
status (nonsmokers, ex-smokers, and current smokers) in
all samples. Second, for current smokers, the risks of smok-
ing exposure (daily cigarette consumption, age at starting
smoking, cumulative smoking years) were analyzed. Final-
ly, for ex-smokers, the risk of smoking history (cumulative
smoking years, years after quitting) on morbidity and
mortality were analyzed. We did not estimate the 7-year
morbidity from cancer because of the absence of cancer
data for the baseline year. Multiple Cox regression analysis
of smoking status relative to morbidity and mortality,
controlling for related factors, was also done.
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RESULTS
In 1989, 36.6% of the initial sample were aged 60–64
years, 28.5% were aged 65–69 years, 17.9% were aged 70–
74 years, and 17.0% were aged 75 years or above. There
were more men (57.1%, n = 2,311) than women (42.9%,
n = 1,738). Half (50.3%) of the elderly were illiterate or
without formal education, 30.7% had attended elementary
school, and 18.9% were educated to junior high school or
above. Of the sample, 60.9% were Ming-Nan, 15.0% were
Hakka, 22.4% came from mainland provinces, and 1.7%
were of other ethnic groups. Overall, 18.2% were physically
disabled.
Of the initial sample of 4,049, 21.7% had heart disease,
4.3% had had a stroke, 8.4% had diabetes, 18.5% had lower
respiratory tract disease, 27.2% had digestive system disease,
and 6.3% had kidney disease. In 1993, the prevalence of
cancer was 1.7%.
In 1989, there were 2,033 (50.2%) nonsmokers, 616
(15.2%) ex-smokers, and 1,399 (34.6%) current smokers (1
case was missing). In 1996, 670 of 2,669 (25.1%) complete
respondents still smoked. Most smokers were male. In
1989, 55.3% of men were current smokers, 24.4% were ex-
smokers, and 20.4% were nonsmokers. Of the women, only
7.0% were current smokers, 3.0% were ex-smokers, and
90.0% were nonsmokers. The younger elderly had a higher
rate of smoking. In 1989, the current smoking rate was
36.8% for those aged 60–74 and 24.0% for those aged 75 or
above.
Of the current smokers, 1,326 of 1,385 (95.7%) complete
cases were long-term smokers (smoking history > 20 years);
483 of 594 (81.3%) ex-smokers had smoked for more than
20 years. Among the 1,390 current smokers (9 cases were
missing), the daily cigarette consumption was less than
10 cigarettes for 44.1% and 11–20 cigarettes for 50.9%, while
only 5.0% smoked more than 20 cigarettes per day. For
ex-smokers, about 40% had quit smoking within the past
5 years, while 25.5% had quit for 20 years or more.
The univariate RR of morbidity and mortality for dif-
ferent smoking status is shown in Table 1. Smokers were
more likely to have lower respiratory tract disease (RR, 1.6
for current smokers, 1.4 for ex-smokers; PAR, 17.2% from
1989 to 1996). Current smokers also had a higher risk over
the two intervals 1989–1993 and 1993–1996. In addition,
current smokers had a higher risk of stroke from 1989 to
1993 (RR, 1.6; PAR, 17.2%). The 1993–1996 RR of cancer was
higher for ex-smokers.
For current smokers, univariate Cox regression was
used to analyze the risk of daily cigarette consumption, age
at starting smoking, and cumulative smoking years on the
7-year incidence of disease and mortality (Table 2). How-
ever, no dose-response relationship was found. We also
analyzed the risk of cumulative smoking years and the
years since quitting on the 7-year incidence of disease and
mortality for ex-smokers (Table 3). Smoking history did
not have a significant impact on the relative risks of mor-
bidity or mortality.
Table 4 shows the multiple Cox regression models for
smoking status relative to morbidity and mortality,
controlling for demographic and related health factors.
Smoking status influenced only lower respiratory tract
disease: current (RR, 1.7) and ex-smokers (RR, 1.4) were
more likely to have respiratory disease. Comorbidity with
other diseases was also more likely to increase the incidence
of morbidity. The older elderly with comorbidity and
physical disability had a higher risk of mortality.
DISCUSSION
This study used a 7-year national longitudinal dataset from
Taiwan to explore the RRs of morbidity and mortality with
respect to smoking status, smoking history, and the cessation
of smoking among the elderly. The smoking elderly had
a higher RR of lower respiratory tract disease (1.6; PAR,
17.2%), as did ex-smokers (RR, 1.4). Ex-smokers had a
higher risk of cancer morbidity. However, for both current
smokers and quitters at the 7-year follow-up, the dose-
response relationship of smoking consumption, smoking
history, and years of cessation was not associated signifi-
cantly with morbidity and mortality risks.
The prevalence of elderly smoking in Taiwan was stable
from 1989 to 1996 in this study. According to the 1989
survey, smoking prevalence among the elderly was 34.6%,
with 15.2% who had quit smoking and 50.2% who had
never smoked. The 1996 prevalence was similar to that in
1989. Prospective panel data suggest that there may have
been changes in smoking behavior during the 7 years of
follow-up. However, the three surveys did not all include
the complete set of variables for smoking exposure, so we
could only estimate the exposure according to the baseline
year.
Current smoking status was associated with the
incidence of stroke, lower respiratory tract disease, and
cancer using univariate Cox models, and the effect on
respiratory disease persisted in the multivariate model.
Respiratory disease can be very sensitive to smoking
behavior, as other case-control studies and prospective
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Table 1. Incidence of disease and mortality by smoking status among the elderly between 1989 and 1996: relative risk (95%
confidence interval)
1989–1993 1993–1996 1989–1996
Heart disease
   Current smokers 0.95 (0.8–1.2) 0.8 (0.6–1.1) 0.9 (0.7–1.1)
   Ex-smokers 0.96 (0.69–1.3) 0.8 (0.6–1.2) 0.9 (0.7–1.2)
   PAR of smoking –1.8% –7.4% –3.6%
Stroke
   Current smokers 1.6 (1.1–2.3) 0.7 (0.4–1.2) 1.1 (0.8–1.6)
   Ex-smokers 1.3 (0.8–2.2) 1.8 (1.0–3.1) 1.5 (1.0–2.3)
   PAR of smoking 17.2% –11.6% 3.3%
Diabetes
   Current smokers 0.9 (0.6–1.2) 0.8 (0.6–1.3) 0.9 (0.7–1.2)
   Ex-smokers 1.0 (0.6–1.6) 0.8 (0.5–1.5) 1.1 (0.7–1.6)
   PAR of smoking –3.6% –7.4% –3.6%
Cancer
   Current smokers – 1.4 (0.6–3.2) –
   Ex-smokers – 2.8 (1.2–6.7) –
   PAR of smoking – 12.2% –
Lower respiratory tract disease
   Current smokers 1.5 (1.2–2.0) 1.7 (1.2–2.3) 1.6 (1.3–2.0)
   Ex-smokers 1.2 (0.9–1.8) 1.9 (1.3–2.8) 1.4 (1.0–1.9)
   PAR of smoking 14.7% 19.5% 17.2%
Digestive disease
   Current smokers 1.2 (0.9–1.6) 0.8 (0.7–1.1) 1.0 (0.8–1.2)
   Ex-smokers 1.0 (0.7–1.5) 1.0 (0.7–1.4) 0.8 (0.6–1.2)
   PAR of smoking 6.5% –7.4% 0%
Kidney disease
   Current smokers 0.7 (0.5–1.0) 0.9 (0.6–1.3) 0.8 (0.6–1.1)
   Ex-smokers 0.7 (0.4–1.1) 0.7 (0.4–1.2) 0.7 (0.4–1.0)
   PAR of smoking –11.6% –3.6% –7.4%
Mortality
   Current smokers 1.0 (0.9–1.2) 1.2 (1.0–1.5) 1.2 (1.0–1.5)
   Ex-smokers 1.3 (1.0–1.6) 1.3 (1.0–1.7) 1.3 (1.0–1.7)
   PAR of smoking 0% 6.5% 6.5%
Reference group is nonsmokers. PAR = population-attributable risk.
Table 2. Incidence of disease and mortality by cigarette consumption and smoking history among elderly current smokers
during 7-year follow-up, 1989–1996: relative risk (95% confidence interval)
Heart
Lower
Digestive Kidney
disease
Stroke Diabetes respiratory
disease disease
Mortality
tract disease
Daily cigarette consumption
   ≤ 10 1.0 1.0 1.0 1.0 1.0 1.0 1.0
   11–20 0.7 (0.5–1.0) 0.8 (0.5–1.3) 1.0 (0.6–1.6) 1.2 (0.8–1.6) 0.9 (0.6–1.3) 0.6 (0.4–1.0) 1.0 (0.7–1.4)
   ≥ 21 0.9 (0.5–1.7) 1.0 (0.3–2.8) 1.0 (0.3–2.8) 1.2 (0.6–2.4) 1.4 (0.7–2.7) 0.7 (0.3–2.0) 0.6 (0.3–1.4)
Age of starting smoking (yr)
   < 20 1.0 1.0 1.0 1.0 1.0 1.0 1.0
   ≥ 20 0.8 (0.6–1.2) 0.9 (0.5–1.5) 0.8 (0.5–1.3) 0.9 (0.7–1.3) 1.2 (0.8–1.8) 0.9 (0.5–1.4) 0.8 (0.6–1.1)
Cumulative smoking years
   0–20 1.0 1.0 1.0 1.0 1.0 1.0 1.0
   ≥ 21 0.9 (0.4–2.0) 1.0 (0.2–3.9) 0.7 (0.2–2.2) 0.9 (0.4–2.1) 1.3 (0.4–4.0) 0.6 (0.2–1.6) 1.7 (0.5–5.4)
Only those who were smokers according to their 1989 smoking status are included in this table.
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Table 3. Incidence of disease and mortality by smoking history among ex-smokers during 7-year follow-up, 1989–1996:
relative risk (95% confidence interval)
Heart
Lower
Digestive Kidney
disease
Stroke Diabetes respiratory
disease disease
Mortality
tract disease
Cumulative smoking years
   1–5 1.0 1.0 1.0 1.0 1.0 1.0 1.0
   6–20 1.5 (0.3–6.7) ∞ 0.4 (0.1–1.6) 1.0 (0.3–3.7) 0.6 (0.2–1.7) 1.0 (0.2–4.6) 1.6 (0.2–13.4)
   ≥ 21 1.1 (0.3–4.7) ∞ 0.6 (0.2–2.0) 1.2 (0.4–3.8) 0.4 (0.2–1.1) 0.6 (0.1–2.6) 4.3 (0.6–31.2)
Years since quitting
   1–5 1.0 1.0 1.0 1.0 1.0 1.0 1.0
   6–20 0.8 (0.4–1.5) 1.5 (0.6–3.5) 1.0 (0.5–2.2) 0.6 (0.3–1.1) 1.2 (0.5–2.6) 0.9 (0.4–2.3) 0.9 (0.4–2.3)
   ≥ 21 1.1 (0.6–2.0) 2.1 (0.9–4.8) 0.8 (0.3–1.9) 0.9 (0.5–1.6) 1.8 (0.9–3.9) 0.9 (0.4–2.4) 0.9 (0.4–2.4)
Only those who had quit smoking according to their smoking status in 1989 are included in this table. Some cells show “∞” because of non-
convergence of parameters in iterations.
Table 4. Incidence of disease and mortality by smoking status and other risk factors among the elderly by Cox multiple
regression models, 1989–1996: relative risk (95% confidence interval)
Heart
Lower
Digestive Kidney
disease
Stroke Diabetes respiratory
disease disease
Mortality
tract disease
Smoking status
   Current smoker 1.1 (0.8–1.5) 0.8 (0.5–1.3) 1.2 (0.8–1.8) 1.7 (1.2–2.3) 0.7 (0.5–1.0) 0.8 (0.6–1.2) 1.2 (0.9–1.6)
   Ex-smoker 1.1 (0.8–1.5) 1.0 (0.6–1.7) 1.4 (0.9–2.3) 1.4 (1.0–2.1) 0.8 (0.6–1.1) 0.7 (0.4–1.1) 1.2 (0.9–1.6)
   Nonsmoker 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Age (yr)
   ≥ 75 1.0 (0.7–1.3) 1.0 (0.6–1.7) 0.5 (0.3–0.96) 1.3 (1.0–1.8) 0.9 (0.6–1.3) 0.6 (0.4–1.0) 2.8 (2.3–3.4)
   60–74 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Gender
   Male 0.7 (0.6–1.0) 1.7 (1.1–2.6) 0.6 (0.4–0.96) 1.1 (0.8–1.5) 1.3 (1.0–1.8) 1.0 (0.7–1.4) 1.3 (1.0–1.7)
   Female 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Education level
   High 1.0 (0.7–1.2) 0.8 (0.6–1.3) 0.8 (0.6–1.2) 0.5 (0.4–0.7) 1.1 (0.8–1.4) 0.8 (0.5–1.1) 0.8 (0.6–1.0)
   Low 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Ethnic group
   Ming-Nan 1.0 (0.8–1.2) 0.7 (0.5–0.98) 0.9 (0.7–1.2) 0.8 (0.7–1.0) 1.2 (1.0–1.5) 1.2 (0.9–1.5) 1.2 (1.0–1.4)
   Others 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Comorbidity 1.3 (1.2–1.5) 1.4 (1.2–1.6) 1.1 (0.95–1.3) 1.2 (1.1–1.4) 1.2 (1.0–1.3) 1.4 (1.2–1.6) 1.3 (1.2–1.4)
Physical function
   Disabled 1.0 (0.7–1.3) 1.2 (0.7–1.9) 0.8 (0.5–1.3) 1.2 (0.8–1.6) 0.9 (0.6–1.3) 0.9 (0.6–1.4) 1.8 (1.4–2.3)
   Normal 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Education level: low = illiterate, no formal education, elementary school, junior high school; high = senior high school and over. Ethnic group: others
include Hakka, mainland provinces, and others. Incidence of disease models, comorbidity = cumulative prevalent numbers of other 5 diseases in
1989; mortality model, comorbidity = cumulative numbers of 6 diseases in 1989. Smoking status, age, and physical function according to 1989 status.
studies have shown [8,18,26]. Ex-smokers had a lower risk
of morbidity than current smokers. Smoking cessation
may thus be a protective factor. A previous study did not
find a dose-response relationship between smoking ex-
posure and mortality in the elderly [17], and the effect of
smoking cessation is not significant [14–16]. This can
possibly be explained as follows.
First, all subjects in our study were aged 60 years and
over. Some elderly might have had diseases attributed to
smoking before they entered their old age, or smoking
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might have shortened their life. These persons with early
morbidity or immature mortality were lost or not eligible
for our analysis at baseline. Thus, the different results ob-
tained here may be attributed to a different study design
and sample. Our study was based on a national represen-
tative and prospective elderly population, rather than a
case-controlled one or targeted at specific patients. Using
such a longitudinal study design limited the incidence
and case numbers and may have made the observation of
a dose-response relationship difficult. Thus, the risk of
smoking might have been underestimated.
Second, smoking behavior is changeable. Patients with
severe diseases often have stronger motivation to quit
smoking [27]. The elderly might have sensed their frailty or
the presence of disease and quit smoking before the sur-
veys. Cessation of smoking might thus be combined with
other changes in health behavior, which might create a
survival advantage. Further, quitting smoking might re-
duce risks immediately (such as after surgery or myocar-
dial infarction) for some patients [14,15]. The effect of ces-
sation over the long-term thus cannot be observed.
Third, the variation in smoking exposure among these
elderly was limited (elderly smokers were mostly long-
term smokers and also low-consumption smokers), so the
dose-response relationship might have been masked.
Subjects were divided into two ethnic groups, Ming-
Nan and others, in the multivariate model. Initially, it had
been separated into Ming-Nan, Hakka, mainland provinces,
and others, but because of the limited cases in this longi-
tudinal study and the many parameters in the multivari-
ate model, we categorized independent variables into fewer
groups to avoid convergence problems in Cox regression
estimation. We considered the sample numbers in each
ethnic group, the lower incidence of morbidity in the Ming-
Nan group, and because the purpose of using ethnic groups
was only for control variables, we conducted the analysis
with these two groups. Readers should be careful to note
that this might mingle the effects of Hakka, mainland
province or aboriginal ethnic origin.
This study is subject to a number of limitations. First, the
data came from a face-to-face self-report survey, and the
accuracy of disease prevalence and recall bias about smoking
history should be considered. In addition, the perception of
hypertension, heart disease, stroke, and so on, might be in-
accurate. Second, cancer prevalence was not available in
the 1989 survey, and the different kinds of cancers could not
be differentiated in the 1993 and 1996 data; therefore, the
relative risks of cancer over the 7 years could not be estimated.
Measures of physical function were not consistent across
the three surveys: in 1993 and 1996, physical function was
measured using six activities of daily living (ADL) (eating,
dressing, walking indoors, transferring from bed or chair,
using the toilet, taking a bath), but in 1989, the physical
function included only one ADL and three instrumental
ADL items. The physical function variable was a more
advanced activity. Third, the variables in the surveys for
each year were not the same, and some information was
not available. For example, there was no quitting smoking
and cigarette consumption data in the 1993 survey, so the
dynamic changes in years since quitting, cumulative smok-
ing years, and daily consumption of cigarettes during
these 7 years were unavailable. Fourth, some cases were
lost to follow-up or died during the longitudinal study. Al-
though we compared the demographic and smoking sta-
tus of the lost cases and the initial cases and found no dif-
ference, the morbidity and mortality of the lost cases is
unknown. Additionally, if smoking shortened the time
from morbidity to death or increased the mortality from
diseases, or smoking induced cancer during the subject’s
middle age, or individuals were dead before their old
age, then the RR of smoking for such a longitudinal study
might be underestimated.
In this study, we analyzed the RRs of smoking on
morbidity and mortality among the elderly population in
Taiwan. Smoking has its greatest effect on morbidity from
respiratory disease in the elderly. The effect of years since
cessation was not clear. We suggest that the protective
effect of smoking cessation should be investigated from
middle age to old age. Further studies should emphasize
the observation of dynamic smoking behavior and be based
on a life-course perspective because health status and health
behavior is changeable. In terms of promotion of successful
aging, we suggest that health promotion for the elderly
should start at an earlier age and continue throughout old
age.
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